Virginia / 2026 Regular Session

2026 Regular Session · Imported snapshot

HB1006: Schedule VI controlled substances; TPA-certified optometrists permitted to sell and dispense.

signed by governor

<b>TPA-certified optometrists; sale and dispensation of Schedule VI controlled substances; requirements.</b> Permits TPA-certified optometrists to sell and dispense Schedule VI controlled substances to their own patients provided that they obtain a license to do so from the Board of Pharmacy and comply with requirements related to dispensation, storage, packaging, labeling, recordkeeping, and reporting of the controlled substances sold and dispensed. The bill permits the Board of Optometry and the Board of Pharmacy to adopt regulations to implement the provisions of the bill and establish a limited-use license for TPA-certified optometrists pursuant to the bill. The bill exempts such initial regulations from the APA requirements. This bill is identical to SB 212.

Official bill page · Source: Richmond Sunlight

Ask about HB1006

Full bill text

Version CHAP0929 · 2026-04-13 · Official source text

Full text

Changes in this version: added text deleted text

An Act to amend and reenact § 54.1-3304.1 of the Code of Virginia and to amend the Code of Virginia by adding a section numbered 54.1-3222.1, relating to TPA-certified optometrists; selling and dispensing Schedule VI controlled substances; requirements.

Be it enacted by the General Assembly of Virginia:

1. That § 54.1-3304.1 of the Code of Virginia is amended and reenacted and that the Code of Virginia is amended by adding a section numbered 54.1-3222.1 as follows:

§ 54.1-3222.1. Selling and dispensing Schedule VI controlled substances by TPA-certified optometrist; requirements.

A. A TPA-certified optometrist may sell and dispense any Schedule VI controlled substances, as defined in § 54.1-3455 of the Drug Control Act (§ 54.1-3400 et seq.), directly to a patient for the treatment of conditions of the eye and its adnexa, provided that:

1. The TPA-certified optometrist is authorized to prescribe the Schedule VI controlled substance pursuant to § 54.1-3222; and

2. Such selling or dispensing is extended only to the optometrist's own patients, and such sale or dispensation complies with the provisions of this section.

B. A TPA-certified optometrist shall not engage in selling or dispensing a Schedule VI controlled substance unless he is licensed to do so by the Board of Pharmacy. The premises of a TPA-certified optometrist who sells or dispenses a Schedule VI controlled substance shall be subject to inspection by the Department of Health Professions to ensure compliance with Chapter 33 (§ 54.1-3300 et seq.), the Drug Control Act (§ 54.1-3400 et seq.), and the Board of Pharmacy's regulations.

C. A TPA-certified optometrist shall (i) be present on the premises at the time the Schedule VI controlled substance is sold and dispensed to a patient and be actively involved in the dispensing process; (ii) inform the patient of the appropriate use of the Schedule VI controlled substance being sold and dispensed; and (iii) comply with all applicable Board of Optometry and Board of Pharmacy regulations concerning the storage, packaging, labeling, recordkeeping, and reporting of the controlled substances sold and dispensed.

D. Dispensing and selling pursuant to this section shall be limited to (i) finished pharmaceutical products that are dispensed and sold strictly in accordance with the manufacturer's labeling and that are in the manufacturer's original, unaltered form; (ii) drugs intended solely for patient self-administration outside the optometrist's office; and (iii) prescriptions that are topical, ophthalmic, or oral in form. No pharmaceutical product dispensed or sold pursuant to this section shall be compounded, repackaged, or otherwise altered by the optometrist.

E. Nothing in this section shall be construed to otherwise expand the administrative or prescriptive authority of a doctor of optometry.

F. The Board of Optometry, in consultation with the Board of Pharmacy, may promulgate regulations to implement the provisions of this section, including provisions for the storage, packaging, labeling, recordkeeping, and reporting of controlled substances dispensed by a TPA-certified optometrist.

§ 54.1-3304.1. Authority to license and regulate practitioners; permits.

A. The Board of Pharmacy shall have the authority to license and regulate the dispensing of controlled substances by practitioners of the healing arts. Except as prescribed in this chapter or by Board regulations, it shall be is unlawful for any practitioner of the healing arts to dispense controlled substances within the Commonwealth unless licensed by the Board to sell controlled substances.

B. Facilities from which practitioners of the healing arts dispense controlled substances shall obtain a permit from the Board and comply with the regulations for practitioners of the healing arts to sell controlled substances. Facilities in which only one practitioner of the healing arts is licensed by the Board to sell controlled substances shall be exempt from fees associated with obtaining and renewing such permit.

C. The Board of Pharmacy may issue a limited-use license for the purpose of dispensing Schedule VI controlled substances, excluding the combination of misoprostol and methotrexate, and hypodermic syringes and needles for the administration of prescribed controlled substances to a doctor of medicine, osteopathic medicine, or podiatry, an advanced practice registered nurse, or a physician assistant, provided that such limited-use licensee is practicing at a nonprofit facility. Such facility shall obtain a limited-use permit from the Board and comply with regulations for such a permit.

D. The Board of Pharmacy may issue a limited-use license to a TPA-certified optometrist for the purpose of dispensing and selling of Schedule VI controlled substances consistent with the provisions of § 54.1-3222.1.

2. That the Board of Optometry and the Board of Pharmacy may promulgate regulations as necessary to implement the provisions of this act and such initial regulations shall be exempt from the Administrative Process Act (§ 2.2-4000 et seq. of the Code of Virginia). The Board of Pharmacy's regulations may include provisions for the issuance of a limited-use license consistent with the provisions of this act.

Legislative actions

2026-03-09 · history

Passed by for the day

2026-03-31 · history

Governor's Action Deadline 11:59 p.m., April 13, 2026

2026-03-11 · history

Reconsideration of Senate passage agreed to by Senate Block Vote (40-Y 0-N 0-A)

2026-03-30 · history

Signed by President

2026-03-11 · history

Passed Senate Block Vote (39-Y 0-N 0-A)

2026-03-06 · history

Reported from Finance and Appropriations (14-Y 0-N)

2026-03-10 · history

Read third time

2026-03-09 · history

Rules suspended

2026-02-16 · history

Engrossed by House - committee substitute

2026-02-12 · history

Reported from Health and Human Services with substitute (21-Y 0-N)

2026-01-23 · history

Assigned sub: Health Professions

2026-02-16 · history

Read second time

2026-02-26 · history

Reported from Education and Health and rereferred to Finance and Appropriations (14-Y 0-N)

2026-02-17 · history

Read third time and passed House Block Vote (97-Y 0-N 0-A)

2026-01-22 · history

Fiscal Impact Statement from Department of Planning and Budget (HB1006)

2026-04-13 · history

Acts of Assembly Chapter text (CHAP0929)

2026-01-14 · history

Referred to Committee on Health and Human Services

2026-02-18 · history

Referred to Committee on Education and Health

2026-03-11 · history

Read third time

2026-02-15 · history

Read first time

2026-04-13 · history

Approved by Governor-Chapter 929 (effective 7/1/2026)

2026-01-28 · history

Fiscal Impact Statement from Department of Planning and Budget (HB1006)

2026-03-11 · history

Passed Senate with amendment Block Vote (39-Y 0-N 0-A)

2026-03-09 · history

Constitutional reading dispensed Block Vote (on 2nd reading) (40-Y 0-N 0-A)

2026-03-31 · history

Fiscal Impact Statement from Department of Planning and Budget (HB1006)

2026-02-10 · history

Subcommittee recommends reporting with substitute (10-Y 0-N)

2026-03-11 · history

Passed Senate Block Vote (39-Y 0-N 0-A)

2026-03-11 · history

Passed Senate Block Vote (40-Y 0-N 0-A)

2026-02-18 · history

Constitutional reading dispensed (on 1st reading)

2026-03-30 · history

Bill text as passed House and Senate (HB1006ER)

2026-03-10 · history

Passed by for the day

2026-02-16 · history

Fiscal Impact Statement from Department of Planning and Budget (HB1006)

2026-03-06 · history

Reported from Finance and Appropriations

2026-03-31 · history

Signed by Speaker

2026-02-10 · history

House subcommittee offered

2026-03-11 · history

Passed Senate with substitute Block Vote (40-Y 0-N 0-A)

2026-03-09 · history

Passed by for the day Block Vote (Voice Vote)

2026-03-31 · history

Enrolled Bill communicated to Governor on March 31, 2026

2026-02-10 · history

Subcommittee recommends reporting with substitute

2026-03-30 · history

Enrolled

2026-02-12 · history

Committee substitute printed 26106082D-H1

2026-02-12 · history

Reported from Health and Human Services with substitute

2026-02-16 · history

committee substitute agreed to

2026-03-11 · history

Passed Senate Block Vote (40-Y 0-N 0-A)

2026-03-11 · history

Passed Senate

2026-01-14 · history

Prefiled and ordered printed; Offered 01-14-2026 26100805D

Raw source record
{
    "id": 84855,
    "url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/hb1006\/",
    "tags": {
        "149675": "medicine",
        "149676": "optometrists",
        "149677": "pharmacy",
        "149678": "regulation",
        "149679": "license",
        "149680": "controlled substances",
        "154358": "optometry"
    },
    "text": [
        {
            "date": "2026-01-14",
            "number": "HB1006",
            "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb1006.pdf"
        },
        {
            "date": "2026-02-12",
            "number": "HB1006H1"
        },
        {
            "date": "2026-03-30",
            "number": "HB1006ER"
        },
        {
            "date": "2026-04-13",
            "number": "CHAP0929"
        }
    ],
    "type": "bill",
    "year": 2026,
    "video": null,
    "number": "hb1006",
    "patron": "Tran, Kathy",
    "status": "signed by governor",
    "chamber": "house",
    "changes": null,
    "outcome": "passed",
    "related": [
        {
            "id": 84178,
            "name": "Finance",
            "year": 2026,
            "count": 7,
            "number": "sb212",
            "status": "signed by governor",
            "catch_line": "Schedule VI controlled substances; TPA-certified optometrists permitted to sell and dispense.",
            "date_introduced": "January 09, 2026"
        },
        {
            "id": 85309,
            "name": "Education and Health",
            "year": 2026,
            "count": 3,
            "number": "sb331",
            "status": "signed by governor",
            "catch_line": "Veterinary Medicine, Board of; traineeships.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 84760,
            "name": null,
            "year": 2026,
            "count": 3,
            "number": "hb917",
            "status": "failed committee",
            "catch_line": "Compounding pharmacies; use of bulk drug substances, recordkeeping.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 84875,
            "name": null,
            "year": 2026,
            "count": 3,
            "number": "hb1026",
            "status": "signed by governor",
            "catch_line": "Foreign-trained chiropractors; licensure by endorsement.",
            "date_introduced": "January 14, 2026"
        },
        {
            "id": 85498,
            "name": null,
            "year": 2026,
            "count": 3,
            "number": "hb1347",
            "status": "signed by governor",
            "catch_line": "Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes.",
            "date_introduced": "January 19, 2026"
        }
    ],
    "summary": "<b>TPA-certified optometrists; sale and dispensation of Schedule VI controlled substances; requirements.<\/b> Permits TPA-certified optometrists to sell and dispense Schedule VI controlled substances to their own patients provided that they obtain a license to do so from the Board of Pharmacy and comply with requirements related to dispensation, storage, packaging, labeling, recordkeeping, and reporting of the controlled substances sold and dispensed. The bill permits the Board of Optometry and the Board of Pharmacy to adopt regulations to implement the provisions of the bill and establish a limited-use license for TPA-certified optometrists pursuant to the bill. The bill exempts such initial regulations from the APA requirements. This bill is identical to SB 212.",
    "version": "CHAP0929",
    "copatron": null,
    "committee": null,
    "full_text": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3304.1\/'>54.1-3304.1<\/a> of the Code of Virginia and to amend the Code of Virginia by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222.1\/'>54.1-3222.1<\/a>, relating to TPA-certified optometrists; selling and dispensing Schedule VI controlled substances; requirements.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3304.1\/'>54.1-3304.1<\/a> of the Code of Virginia is amended and reenacted and that the Code of Virginia is amended by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222.1\/'>54.1-3222.1<\/a> as follows:<\/p><p class=\"catchln\"><em class=\"new\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222.1\/'>54.1-3222.1<\/a>. Selling and dispensing Schedule VI controlled substances by TPA-certified optometrist; requirements.<\/ins><\/p><p class=\"section\"><em class=\"new\">A. A TPA-certified optometrist may sell and dispense any Schedule VI controlled substances, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3455\/'>54.1-3455<\/a> of the Drug Control Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3400\/'>54.1-3400<\/a> et seq.), directly to a patient for the treatment of conditions of the eye and its adnexa, provided that:<\/ins><\/p><p class=\"section\"><em class=\"new\">1. The TPA-certified optometrist is authorized to prescribe the Schedule VI controlled substance pursuant to \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222\/'>54.1-3222<\/a>; and<\/ins><\/p><p class=\"section\"><em class=\"new\">2. Such selling or dispensing is extended only to the optometrist's own patients, and such sale or dispensation complies with the provisions of this section.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. A TPA-certified optometrist shall not engage in selling or dispensing a Schedule VI controlled substance unless he is licensed to do so by the Board of Pharmacy. The premises of a TPA-certified optometrist who sells or dispenses a Schedule VI controlled substance shall be subject to inspection by the Department of Health Professions to ensure compliance with Chapter 33 (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3300\/'>54.1-3300<\/a> et seq.), the Drug Control Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3400\/'>54.1-3400<\/a> et seq.), and the Board of Pharmacy's regulations.<\/ins><\/p><p class=\"section\"><em class=\"new\">C. A TPA-certified optometrist shall (i) be present on the premises at the time the Schedule VI controlled substance is sold and dispensed to a patient and be actively involved in the dispensing process; (ii) inform the patient of the appropriate use of the Schedule VI controlled substance being sold and dispensed; and (iii) comply with all applicable Board of Optometry and Board of Pharmacy regulations concerning the storage, packaging, labeling, recordkeeping, and reporting of the controlled substances sold and dispensed.<\/ins><\/p><p class=\"section\"><em class=\"new\">D. Dispensing and selling pursuant to this section shall be limited to (i) finished pharmaceutical products that are dispensed and sold strictly in accordance with the manufacturer's labeling and that are in the manufacturer's original, unaltered form; (ii) drugs intended solely for patient self-administration outside the optometrist's office; and (iii) prescriptions that are topical, ophthalmic, or oral in form. No pharmaceutical product dispensed or sold pursuant to this section shall be compounded, repackaged, or otherwise altered by the optometrist.<\/ins><\/p><p class=\"section\"><em class=\"new\">E. Nothing in this section shall be construed to otherwise expand the administrative or prescriptive authority of a doctor of optometry.<\/ins><\/p><p class=\"section\"><em class=\"new\">F. The Board of Optometry, in consultation with the Board of Pharmacy, may promulgate regulations to implement the provisions of this section, including provisions for the storage, packaging, labeling, recordkeeping, and reporting of controlled substances dispensed by a TPA-certified optometrist.<\/ins><\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3304.1\/'>54.1-3304.1<\/a>. Authority to license and regulate practitioners; permits.<\/p><p class=\"section\">A. The Board of Pharmacy shall have the authority to license and regulate the dispensing of controlled substances by practitioners of the healing arts. Except as prescribed in this chapter or by Board regulations, it<s> shall be<\/s><em class=\"new\"> is<\/ins> unlawful for any practitioner of the healing arts to dispense controlled substances within the Commonwealth unless licensed by the Board to sell controlled substances.<\/p><p class=\"section\">B. Facilities from which practitioners of the healing arts dispense controlled substances shall obtain a permit from the Board and comply with the regulations for practitioners of the healing arts to sell controlled substances. Facilities in which only one practitioner of the healing arts is licensed by the Board to sell controlled substances shall be exempt from fees associated with obtaining and renewing such permit.<\/p><p class=\"section\">C. The Board of Pharmacy may issue a limited-use license for the purpose of dispensing Schedule VI controlled substances, excluding the combination of misoprostol and methotrexate, and hypodermic syringes and needles for the administration of prescribed controlled substances to a doctor of medicine, osteopathic medicine, or podiatry, an advanced practice registered nurse, or a physician assistant, provided that such limited-use licensee is practicing at a nonprofit facility. Such facility shall obtain a limited-use permit from the Board and comply with regulations for such a permit.<\/p><p class=\"section\"><em class=\"new\">D. The Board of Pharmacy may issue a limited-use license to a TPA-certified optometrist for the purpose of dispensing and selling of Schedule VI controlled substances consistent with the provisions of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222.1\/'>54.1-3222.1<\/a>.<\/ins><\/p><p class=\"enactcls\">2. That the Board of Optometry and the Board of Pharmacy may promulgate regulations as necessary to implement the provisions of this act and such initial regulations shall be exempt from the Administrative Process Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/2.2-4000\/'>2.2-4000<\/a> et seq. of the Code of Virginia). The Board of Pharmacy's regulations may include provisions for the issuance of a limited-use license consistent with the provisions of this act.<\/p>",
    "catch_line": "Schedule VI controlled substances; TPA-certified optometrists permitted to sell and dispense.",
    "duplicates": null,
    "session_id": 32,
    "word_count": 1041,
    "patron_party": "D",
    "patron_place": "Springfield",
    "summary_hash": "972d50987b0df3a48dd62ee474ccad27",
    "patron_prefix": "Del.",
    "patron_suffix": "(D-Springfield)",
    "status_detail": "signed by governor",
    "_rsun_versions": [
        {
            "id": "64bda2c942deb86ced7da0f0927dfe664f26c14ead42f1b696b6d8b729c0a6c0",
            "code": "CHAP0929",
            "bill_id": 84855,
            "source_url": null,
            "source_date": "2026-04-13",
            "source_hash": "be90b27f1162bfcecb5a34a0ba2af4958060bf82e73274752f23f0046b138f9c",
            "source_html": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3304.1\/'>54.1-3304.1<\/a> of the Code of Virginia and to amend the Code of Virginia by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222.1\/'>54.1-3222.1<\/a>, relating to TPA-certified optometrists; selling and dispensing Schedule VI controlled substances; requirements.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3304.1\/'>54.1-3304.1<\/a> of the Code of Virginia is amended and reenacted and that the Code of Virginia is amended by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222.1\/'>54.1-3222.1<\/a> as follows:<\/p><p class=\"catchln\"><em class=\"new\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222.1\/'>54.1-3222.1<\/a>. Selling and dispensing Schedule VI controlled substances by TPA-certified optometrist; requirements.<\/ins><\/p><p class=\"section\"><em class=\"new\">A. A TPA-certified optometrist may sell and dispense any Schedule VI controlled substances, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3455\/'>54.1-3455<\/a> of the Drug Control Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3400\/'>54.1-3400<\/a> et seq.), directly to a patient for the treatment of conditions of the eye and its adnexa, provided that:<\/ins><\/p><p class=\"section\"><em class=\"new\">1. The TPA-certified optometrist is authorized to prescribe the Schedule VI controlled substance pursuant to \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222\/'>54.1-3222<\/a>; and<\/ins><\/p><p class=\"section\"><em class=\"new\">2. Such selling or dispensing is extended only to the optometrist's own patients, and such sale or dispensation complies with the provisions of this section.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. A TPA-certified optometrist shall not engage in selling or dispensing a Schedule VI controlled substance unless he is licensed to do so by the Board of Pharmacy. The premises of a TPA-certified optometrist who sells or dispenses a Schedule VI controlled substance shall be subject to inspection by the Department of Health Professions to ensure compliance with Chapter 33 (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3300\/'>54.1-3300<\/a> et seq.), the Drug Control Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3400\/'>54.1-3400<\/a> et seq.), and the Board of Pharmacy's regulations.<\/ins><\/p><p class=\"section\"><em class=\"new\">C. A TPA-certified optometrist shall (i) be present on the premises at the time the Schedule VI controlled substance is sold and dispensed to a patient and be actively involved in the dispensing process; (ii) inform the patient of the appropriate use of the Schedule VI controlled substance being sold and dispensed; and (iii) comply with all applicable Board of Optometry and Board of Pharmacy regulations concerning the storage, packaging, labeling, recordkeeping, and reporting of the controlled substances sold and dispensed.<\/ins><\/p><p class=\"section\"><em class=\"new\">D. Dispensing and selling pursuant to this section shall be limited to (i) finished pharmaceutical products that are dispensed and sold strictly in accordance with the manufacturer's labeling and that are in the manufacturer's original, unaltered form; (ii) drugs intended solely for patient self-administration outside the optometrist's office; and (iii) prescriptions that are topical, ophthalmic, or oral in form. No pharmaceutical product dispensed or sold pursuant to this section shall be compounded, repackaged, or otherwise altered by the optometrist.<\/ins><\/p><p class=\"section\"><em class=\"new\">E. Nothing in this section shall be construed to otherwise expand the administrative or prescriptive authority of a doctor of optometry.<\/ins><\/p><p class=\"section\"><em class=\"new\">F. The Board of Optometry, in consultation with the Board of Pharmacy, may promulgate regulations to implement the provisions of this section, including provisions for the storage, packaging, labeling, recordkeeping, and reporting of controlled substances dispensed by a TPA-certified optometrist.<\/ins><\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3304.1\/'>54.1-3304.1<\/a>. Authority to license and regulate practitioners; permits.<\/p><p class=\"section\">A. The Board of Pharmacy shall have the authority to license and regulate the dispensing of controlled substances by practitioners of the healing arts. Except as prescribed in this chapter or by Board regulations, it<s> shall be<\/s><em class=\"new\"> is<\/ins> unlawful for any practitioner of the healing arts to dispense controlled substances within the Commonwealth unless licensed by the Board to sell controlled substances.<\/p><p class=\"section\">B. Facilities from which practitioners of the healing arts dispense controlled substances shall obtain a permit from the Board and comply with the regulations for practitioners of the healing arts to sell controlled substances. Facilities in which only one practitioner of the healing arts is licensed by the Board to sell controlled substances shall be exempt from fees associated with obtaining and renewing such permit.<\/p><p class=\"section\">C. The Board of Pharmacy may issue a limited-use license for the purpose of dispensing Schedule VI controlled substances, excluding the combination of misoprostol and methotrexate, and hypodermic syringes and needles for the administration of prescribed controlled substances to a doctor of medicine, osteopathic medicine, or podiatry, an advanced practice registered nurse, or a physician assistant, provided that such limited-use licensee is practicing at a nonprofit facility. Such facility shall obtain a limited-use permit from the Board and comply with regulations for such a permit.<\/p><p class=\"section\"><em class=\"new\">D. The Board of Pharmacy may issue a limited-use license to a TPA-certified optometrist for the purpose of dispensing and selling of Schedule VI controlled substances consistent with the provisions of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3222.1\/'>54.1-3222.1<\/a>.<\/ins><\/p><p class=\"enactcls\">2. That the Board of Optometry and the Board of Pharmacy may promulgate regulations as necessary to implement the provisions of this act and such initial regulations shall be exempt from the Administrative Process Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/2.2-4000\/'>2.2-4000<\/a> et seq. of the Code of Virginia). The Board of Pharmacy's regulations may include provisions for the issuance of a limited-use license consistent with the provisions of this act.<\/p>",
            "source_metadata": {
                "bodyAssociation": "archive-reported-current-version",
                "archiveReference": {
                    "date": "2026-04-13",
                    "number": "CHAP0929"
                }
            }
        }
    ],
    "copatron_count": 0,
    "patron_address": [
        "P.O. Box 2731",
        "Springfield",
        "VA 22152"
    ],
    "patron_chamber": "house",
    "patron_started": 2018,
    "session_lis_id": 261,
    "status_history": [
        {
            "date": "04\/13\/2026",
            "status": "Acts of Assembly Chapter text (CHAP0929)",
            "date_raw": "2026-04-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/13\/2026",
            "status": "Approved by Governor-Chapter 929 (effective 7\/1\/2026)",
            "date_raw": "2026-04-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "03\/31\/2026",
            "status": "Signed by Speaker",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/31\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB1006)",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/31\/2026",
            "status": "Governor's Action Deadline 11:59 p.m., April 13, 2026",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/31\/2026",
            "status": "Enrolled Bill communicated to Governor on March 31, 2026",
            "date_raw": "2026-03-31",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/30\/2026",
            "status": "Signed by President",
            "date_raw": "2026-03-30",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed"
        },
        {
            "date": "03\/30\/2026",
            "status": "Bill text as passed House and Senate (HB1006ER)",
            "date_raw": "2026-03-30",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/30\/2026",
            "status": "Enrolled",
            "date_raw": "2026-03-30",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301596",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate Block Vote (39-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301594",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate with substitute  Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301596",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate with amendment  Block Vote (39-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301594",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate  Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301596",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Reconsideration of Senate passage agreed to by Senate  Block Vote (40-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301595",
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Passed Senate  Block Vote (39-Y 0-N 0-A)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": "301594",
            "translation": "passed senate"
        },
        {
            "date": "03\/11\/2026",
            "status": "Read third time",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/10\/2026",
            "status": "Passed by for the day",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/10\/2026",
            "status": "Read third time",
            "date_raw": "2026-03-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/09\/2026",
            "status": "Passed by for the day",
            "date_raw": "2026-03-09",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/09\/2026",
            "status": "Passed by for the day  Block Vote (Voice Vote)",
            "date_raw": "2026-03-09",
            "vote_count": null,
            "lis_vote_id": "301210",
            "translation": null
        },
        {
            "date": "03\/09\/2026",
            "status": "Constitutional reading dispensed  Block Vote (on 2nd reading) (40-Y 0-N 0-A)",
            "date_raw": "2026-03-09",
            "vote_count": null,
            "lis_vote_id": "301209",
            "translation": null
        },
        {
            "date": "03\/09\/2026",
            "status": "Rules suspended",
            "date_raw": "2026-03-09",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/06\/2026",
            "status": "Reported from Finance and Appropriations (14-Y 0-N)",
            "date_raw": "2026-03-06",
            "vote_count": null,
            "lis_vote_id": "300885",
            "translation": "passed committee"
        },
        {
            "date": "03\/06\/2026",
            "status": "Reported from Finance and Appropriations",
            "date_raw": "2026-03-06",
            "vote_count": null,
            "lis_vote_id": "300885",
            "translation": "passed committee"
        },
        {
            "date": "02\/26\/2026",
            "status": "Reported from Education and Health and rereferred to Finance and Appropriations (14-Y 0-N)",
            "date_raw": "2026-02-26",
            "vote_count": null,
            "lis_vote_id": "299073",
            "translation": "passed committee"
        },
        {
            "date": "02\/18\/2026",
            "status": "Referred to Committee on Education and Health",
            "date_raw": "2026-02-18",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "02\/18\/2026",
            "status": "Constitutional reading dispensed (on 1st reading)",
            "date_raw": "2026-02-18",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/17\/2026",
            "status": "Read third time and passed House  Block Vote (97-Y 0-N 0-A)",
            "date_raw": "2026-02-17",
            "vote_count": null,
            "lis_vote_id": "297750",
            "translation": "passed house"
        },
        {
            "date": "02\/16\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB1006)",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "Engrossed by House - committee substitute",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "committee substitute agreed to",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "Read second time",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/15\/2026",
            "status": "Read first time",
            "date_raw": "2026-02-15",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Committee substitute printed 26106082D-H1",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Reported from Health and Human Services with substitute (21-Y 0-N)",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": "296704",
            "translation": "passed committee"
        },
        {
            "date": "02\/12\/2026",
            "status": "Reported from Health and Human Services with substitute",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": "296704",
            "translation": "passed committee"
        },
        {
            "date": "02\/10\/2026",
            "status": "Subcommittee recommends reporting with substitute (10-Y 0-N)",
            "date_raw": "2026-02-10",
            "vote_count": null,
            "lis_vote_id": "295709",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/10\/2026",
            "status": "Subcommittee recommends reporting with substitute",
            "date_raw": "2026-02-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/10\/2026",
            "status": "House subcommittee offered",
            "date_raw": "2026-02-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/28\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB1006)",
            "date_raw": "2026-01-28",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/23\/2026",
            "status": "Assigned sub: Health Professions",
            "date_raw": "2026-01-23",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "01\/22\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB1006)",
            "date_raw": "2026-01-22",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/14\/2026",
            "status": "Referred to Committee on Health and Human Services",
            "date_raw": "2026-01-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "01\/14\/2026",
            "status": "Prefiled and ordered printed; Offered 01-14-2026 26100805D",
            "date_raw": "2026-01-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "introduced"
        }
    ],
    "chief_patron_id": 441,
    "date_introduced": "2026-01-14",
    "patron_district": 18,
    "patron_shortname": "kkltran",
    "committee_chamber": null,
    "status_detail_date": "04\/13\/2026",
    "committee_shortname": null,
    "patron_name_formatted": "Del. Kathy Tran (D-Springfield)"
}